| Literature DB >> 35456877 |
Luísa D F Santos1, Laëtitia Caraty-Philippe1, Emmanuelle Darbon1, Jean-Luc Pernodet1.
Abstract
Actinobacteria of the genus Amycolatopsis are important for antibiotic production and other valuable biotechnological applications such as bioconversion or bioremediation. Despite their importance, tools and methods for their genetic manipulation are less developed than in other actinobacteria such as Streptomyces. We report here the use of the pSAM2 site-specific recombination system to delete antibiotic resistance cassettes used in gene replacement experiments or to create large genomic deletions. For this purpose, we constructed a shuttle vector, replicating in Escherichia coli and Amycolatopsis, expressing the integrase and the excisionase from the Streptomyces integrative and conjugative element pSAM2. These proteins are sufficient for site-specific recombination between the attachment sites attL and attR. We also constructed two plasmids, replicative in E. coli but not in Amycolatopsis, for the integration of the attL and attR sites on each side of a large region targeted for deletion. We exemplified the use of these tools in Amycolatopsis mediterranei by obtaining with high efficiency a marker-free deletion of one single gene in the rifamycin biosynthetic gene cluster or of the entire 90-kb cluster. These robust and simple tools enrich the toolbox for genome engineering in Amycolatopsis.Entities:
Keywords: Amycolatopsis; excision tool; large-scale deletion; marker recycling; pSAM2 site-specific recombination system; unmarked mutant
Year: 2022 PMID: 35456877 PMCID: PMC9033027 DOI: 10.3390/microorganisms10040828
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Strains used in this study.
| Strain | Description | Reference or Source |
|---|---|---|
| General cloning strain | Promega | |
| Host strain for conjugation from | [ | |
| Host strain for conjugation from | [ | |
| Wild-type (WT) strain | DSMZ | |
| DSM 40773 ∆ | This study | |
| DSM 40773 ∆ | Unmarked | This study |
| DSM 40773-pRIF14 | This study | |
| DSM 40773-pRIF12-pRIF14 | This study | |
| DSM 40773 ∆ | This study | |
| Rifamycin sensitive strain used as indicator in bioassay analysis | [ | |
| Rifamycin resistant strain used as indicator in bioassay analysis, | Marick Esberard and Philippe Bouloc unpublished |
Plasmids used in this study.
| Plasmid | Description a | Reference or Source |
|---|---|---|
| pRL60 | [ | |
| pOSV236 | [ | |
| pOSV504 | Source of the excisable hygromycin cassette ( | [ |
| pOJ260 | [ | |
| pOSV805 | [ | |
| pCR-blunt | Invitrogen | |
| pT-atts | pUC derivative containing the | This study |
| pRL60∆ | This study | |
| pEA01 | This study | |
| pEA02 | This study | |
| pEA03 | This study | |
| pRIF01 | pCR-blunt derivative containing the downstream homologous region of | This study |
| pRIF02 | pCR-blunt derivative containing the upstream homologous region of | This study |
| pRIF05 | pOJ260 derivative containing the excisable hygromycin cassette ( | This study |
| pRIF09 | pCR-blunt derivative containing the downstream homologous region of the | This study |
| pRIF10 | pCR-blunt derivative containing the upstream homologous region of the | This study |
| pRIF12 | This study | |
| pRIF14 | This study |
a Abbreviations: amy—α-amylase; R—Resistance, Ery—Erythromycin, Kan—Kanamycin, Amp—Ampicillin, Pur—Puromycin, Apr—Apramycin, Hyg—Hygromycin.
Figure 1Principle of pSAM2 SSR system and examples of its application (schematic representations not to scale). The SSR system requires cis-acting elements (attL and attR sites) and trans-acting elements (xis and int genes). First, the att sites are introduced in the genome via homologous recombination. The attL and attR sites are integrated in the genome by (1) a double event of homologous recombination in which the target is replaced by an excisable cassette/marker; or (2) two single events of homologous recombination after which the target is flanked by the att sites. Then the xis and int genes are introduced and temporarily expressed to perform the excision of the region flanked by attL-attR sites.
Figure 2Maps of the plasmids constructed in this study. All three plasmids are replicative in E. coli. pEA01 can replicate in Amycolatopsis while pEA02 and pEA03 are suicide vectors in Amycolatopsis. aph(3′): kanamycin resistance gene; pBR-ori: pBR322 origin of replication; pA-rep: short replicon region of pA387; pac: puromycin resistance gene; oriT: origin of transfer; int and xis, integrase and excisionase gene of pSAM2; trcp: trc promoter for the expression of xis and int genes; ermE: erythromycin resistance gene; attL: left attachment site; ColE1: ColE1 origin of replication; aac(3)IV: apramycin resistance gene; aph(7″): hygromycin resistance gene; p15A: p15A origin of replication; attR: right attachment site.
Figure 3Construction of an unmarked rifK deletion mutant using an excisable cassette. (A) Schematic representation (not to scale) of the successive steps. First the rifK gene is replaced by the att1Ωhyg cassette via a double homologous recombination event. Then the att1Ωhyg cassette is excised following the introduction of pEA01, resulting in an unmarked deletion mutant containing a 33-bp scar (att1). (B) PCR verification of the strains at different stages of the construction. Verifications are based on three PCRs. The extent of the expected amplicons for each of the PCR is indicated in panel A. The amplicons sizes are indicated on the left side of the pictures. Lanes: ∆rifK::att1Ωhyg- genomic DNA from one of the A. mediterranei DSM43770 ∆rifK::att1Ωhyg clones, representative of all analyzed clones; Ladder-GeneRuler DNA Ladder (SM0331 Thermo Scientific); ∆rifK::att1-genomic DNA from one of the A. mediterranei DSM43770 ∆rifK::att1 clones, representative of all analyzed clones WT-genomic DNA from A. mediterranei DSM43770 wild-type strain; pRIF05-Plasmid pRIF05. (C) Bioassays. The antibacterial activity of the culture supernatants from the wild-type and the mutant strains of A. mediterranei DSM43770 was assayed against S. aureus HG003 (sensitive to rifamycin) and its rpoBH481Y mutant derivative (resistant to rifamycin). MP5 with or without 5 µg/mL of rifamycin SV was used as positive or negative control, respectively.
Figure 4Construction of an unmarked rif cluster deletion mutant. (A) Schematic representation (not to scale) of the successive steps. First the attL and attR sequences are successively integrated upstream and downstream of the rif cluster via two single homologous recombination events. Then the complete region between the attL and attR sites is excised following the introduction of pEA01, resulting in an unmarked rif cluster deletion mutant containing a 33-bp scar (att1). (B) PCR verification of the strains at different stages of the construction. Verifications are based on three PCRs. The extent of the expected amplicons for each of the PCR is indicated in panel A. Lanes: pRIF12-pRIF14-genomic DNA of A. mediterranei DSM43770 harboring pRIF12 and pRIF14, representative of all analyzed exconjugants; Ladder-GeneRuler DNA Ladder (SM0331 Thermo Scientific); WT-genomic DNA of A. mediterranei DSM43770 wild-type strain; pRIF12-Plasmid pRIF12; pRIF14-Plasmid pRIF14; ∆rif::att1-genomic DNA of A. mediterranei with a deletion of the rif cluster. (C) Bioassays. The antibacterial activity of culture supernatants from the wild-type strain A. mediterranei DSM43770, the strain harbouring pRIF12 and pRIF14, and the mutant strain ∆rif::att1 was assayed against S. aureus HG003 (sensitive to rifamycin) and its rpoBH481Y derivative (resistant to rifamycin). The slight difference in inhibition zone size observed for WT and pRIF12-pRIF14 strains is due to the fluctuation of rifamycin production between different flasks. MP5 with or without 5 µg/mL of rifamycin SV was used as positive or negative control, respectively.